DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,203 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $432,490 | -2.8% | 1,731 | -2.8% | 0.16% | +0.6% |
Q1 2024 | $444,751 | +7.9% | 1,781 | 0.0% | 0.16% | -0.6% |
Q4 2023 | $412,017 | -1.1% | 1,781 | +6.1% | 0.16% | -12.0% |
Q3 2023 | $416,560 | -22.1% | 1,679 | -24.7% | 0.18% | -19.3% |
Q2 2023 | $534,960 | +16.0% | 2,229 | +21.9% | 0.23% | +9.1% |
Q1 2023 | $460,981 | -5.8% | 1,829 | -0.8% | 0.21% | -7.9% |
Q4 2022 | $489,434 | +16.3% | 1,844 | +13.2% | 0.23% | -0.9% |
Q3 2022 | $421,000 | +3.4% | 1,629 | +1.6% | 0.23% | +8.5% |
Q2 2022 | $407,000 | -22.3% | 1,604 | -10.1% | 0.21% | -14.2% |
Q1 2022 | $524,000 | -14.2% | 1,785 | -3.8% | 0.25% | -11.8% |
Q4 2021 | $611,000 | -0.3% | 1,856 | -7.8% | 0.28% | -9.7% |
Q3 2021 | $613,000 | +14.6% | 2,013 | +1.0% | 0.31% | +14.9% |
Q2 2021 | $535,000 | +9.6% | 1,993 | -8.1% | 0.27% | +1.1% |
Q1 2021 | $488,000 | -16.2% | 2,168 | -17.2% | 0.27% | -19.4% |
Q4 2020 | $582,000 | -4.1% | 2,618 | -7.1% | 0.33% | -16.9% |
Q3 2020 | $607,000 | +11.0% | 2,818 | -8.9% | 0.40% | +7.3% |
Q2 2020 | $547,000 | +27.8% | 3,093 | 0.0% | 0.37% | +10.8% |
Q1 2020 | $428,000 | -5.3% | 3,093 | +5.1% | 0.33% | +21.0% |
Q4 2019 | $452,000 | +6.4% | 2,943 | 0.0% | 0.28% | +1.5% |
Q3 2019 | $425,000 | +9.5% | 2,943 | +8.5% | 0.27% | 0.0% |
Q2 2019 | $388,000 | +8.4% | 2,712 | 0.0% | 0.27% | +5.0% |
Q1 2019 | $358,000 | +17.0% | 2,712 | -8.5% | 0.26% | +2.4% |
Q4 2018 | $306,000 | -5.0% | 2,963 | 0.0% | 0.25% | +11.5% |
Q3 2018 | $322,000 | +10.3% | 2,963 | 0.0% | 0.23% | -14.0% |
Q2 2018 | $292,000 | -5.8% | 2,963 | -6.3% | 0.26% | -5.4% |
Q1 2018 | $310,000 | +2.0% | 3,163 | -3.3% | 0.28% | +4.1% |
Q4 2017 | $304,000 | +10.9% | 3,271 | +2.2% | 0.27% | +4.3% |
Q3 2017 | $274,000 | -4.5% | 3,202 | -5.8% | 0.26% | -8.5% |
Q2 2017 | $287,000 | -6.2% | 3,399 | -4.9% | 0.28% | -4.1% |
Q1 2017 | $306,000 | +2.3% | 3,574 | -6.8% | 0.29% | -0.7% |
Q4 2016 | $299,000 | – | 3,834 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |